Email Alert RSS
Volume 1 Issue 1
Jul.  2010
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Xiao-yan SHEN, Yang XIANG, Li-na GUO, Feng-zhi FENG, Xi-run WAN, Yu XIAO, Jun ZHAO. Fertility Sparing Therapy in Patients with Intermediate Trophoblastic Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(1): 82-86.
Citation: Xiao-yan SHEN, Yang XIANG, Li-na GUO, Feng-zhi FENG, Xi-run WAN, Yu XIAO, Jun ZHAO. Fertility Sparing Therapy in Patients with Intermediate Trophoblastic Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(1): 82-86.
shu

Fertility Sparing Therapy in Patients with Intermediate Trophoblastic Tumors

  • 1.

    Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

More Information
  • Corresponding author:

    XIANG Yang Tel: 010-65296218, E-mail:jin_zhengyu@163.com

  • Received Date: April 18, 2010
  • Issue Publish Date: July 29, 2010
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the methodologies of fertility sparing therapy in treating intermediate trophoblastic tumors (ITTs) and analyze their outcomes.
      Methods  The clinical data of 6 patients with ITTs who underwent fertility sparing therapy in our department from January 1999 to March 2010 were retrospectively analyzed.
      Results  Serum β-hCG of two patients returned normal after treated by dilation and curettage. Serum β-hCG of two patients returned normal after two courses of combined chemotherapy. Three patients were cured after open uterine tumor resection and combined chemotherapy. The gross pathology of three ITTS were polypoid, which were controlled by combined chemotherapy following dilation and curettage. Two of three patients with nodular masses type were cured by a multi-modality treatments that combined dilation and curettage with chemotherapy, followed by open uterine tumor resection (the other one did not undergo dilation and curettage). The average follow-up time was 35 months. All patients experienced complete remission (CR). Menstruation returned normal in all patients. No recurrence was noted during follow-up. No one had been pregnant.
      Conclusions  Fertility sparing therapy is safe and feasible for ITTs patients under the following conditions:younger than 35 years and having a strong wish to get pregnant in future; the tumor is localized in uterus; and multifocal disease (the diffuse infiltrative type) has been excluded.
    • FullText(HTML)
    • References (14)
  • [1]
    Zhao J, Xiang Y, Wan XR, et al. Clinical and pathologic. characteristics and prognosis of placental site trophoblastic tumor [J]. J Reprod Med, 2006, 51: 939-944. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=c575bb06dac35b02deb16e3e21294dcd
    [2]
    Baergen RN, Rutgers JL, Young RH, et al. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic signifcance[J]. Gynecol Oncol, 2006, 100:511-520. DOI: 10.1016/j.ygyno.2005.08.058
    [3]
    Palmer JE, Macdonald M, Wells M, et al. Epithelioid trophoblastic tumor: a review of the literature[J]. J Reprod Med, 2008, 53: 465-475. http://cn.bing.com/academic/profile?id=684565ef2e7a2b038ad48eaae4282f6b&encoded=0&v=paper_preview&mkt=zh-cn
    [4]
    Schmid P, Nagai Y, Agarwal R, et al. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study[J]. Lancet, 2009, 374: 48-55. DOI: 10.1016/S0140-6736(09)60618-8
    [5]
    Kim SJ. Placental site trophoblastic tumour[J]. Best Pract Res Clin Obstet Gynaecol, 2003, 17: 969 -984. DOI: 10.1016/S1521-6934(03)00095-6
    [6]
    Leiserowitz GS, Webb MJ. Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction [J]. Obstet Gynecol, 1996, 88: 696-699. DOI: 10.1016/0029-7844(96)00124-X
    [7]
    Tsuji Y, Tsubamoto H, Hori M, et al. Case of PSTT treated with chemotherapy fllowed by open uterine tumor resection to preserve fertility[J]. Gynecol Oncol, 2002, 87: 303-307. DOI: 10.1006/gyno.2002.6827
    [8]
    Machtinger R, Gotlieb WH, Korach J, et al. Placental site trophoblastic tumor: outcome of five cases including fertility preserving management[J]. Gynecol Oncol, 2005, 96: 56-61. DOI: 10.1016/j.ygyno.2004.08.049
    [9]
    Numnum TM, Kilgore LC, Conner MG, et al. Fertility sparing therapy in a patient with placental site trophoblastic tumor: a case report[J]. Gyecol Oncol, 2006, 103: 1141-1143. http://cn.bing.com/academic/profile?id=254c1367460a59fb8d13b4af25998def&encoded=0&v=paper_preview&mkt=zh-cn
    [10]
    Liszka L, Wilk M, Wodolazski A, et al. Successful treatment of placental site trophoblastic tumor in twin pregnancy without hysterectomy[J]. Tumori, 2009, 95: 108-111. DOI: 10.1177/030089160909500120
    [11]
    Peffer PE, Sebire N, Lindsay I, et al. Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour[J]. Lancet Oncol, 2007, 8: 744-746. DOI: 10.1016/S1470-2045(07)70243-7
    [12]
    Piura B, Rabinovich A, Meirovitz M, et al. Placental site trophoblastic tumor: report of four cases and review of literature[J]. Int J Gynecol Cancer, 2007, 17: 258-262. DOI: 10.1111/j.1525-1438.2006.00774.x
    [13]
    Ajithkumar TV, Abraham EK, Rejnishkumar R, et al. Placental site trophoblastic tumor[J]. Obstet Gynecol Surv, 2003, 58: 484-488. http://cn.bing.com/academic/profile?id=c229b2f155f71f9a6a072277deafd507&encoded=0&v=paper_preview&mkt=zh-cn
    [14]
    Swisher E, Drescher CW. Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy[J]. Gynecol Oncol, 1998, 68: 62-65. DOI: 10.1006/gyno.1997.4888
    • Related Articles

  • Related Articles

    [1]WANG Ling, WANG Ping, SU Renfeng, ZHAO Junxian, ZHU Di, LI Zhewei, HE Hongfeng, LUO Xufei, LIU Hui, ZHANG Hairong, WANG Xiaohui, CHEN Yaolong. Analysis of Development Method of Clinical Practice Guidelines in Primary Care[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1310-1318. DOI: 10.12290/xhyxzz.2023-0455
    [2]WU Xin, LI Binglu, ZHENG Chaoji. Exploration of General Surgery Clinical Internship Teaching Mode for Medical Students from "4+4" Pilot Class[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 665-668. DOI: 10.12290/xhyxzz.2022-0177
    [3]LI Tao, ZHANG Kan, YANG Wenyu, LIU Lu, ZHENG Xuan, ZHANG Fan, HU Yi. Clinical Application of Immune Checkpoint Inhibitors CTLA-4 in Solid Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 652-659. DOI: 10.12290/xhyxzz.2022-0617
    [4]CHEN Di, YU Weihong, ZHANG Xiao, ZHANG Yang, ZHANG Meifen. Application of Differentiated Training Program for Ophthalmic Postdoctoral Trainees in Peking Union Medical College Hospital[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(1): 61-65. DOI: 10.12290/xhyxzz.2021-0537
    [5]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅴ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 658-665. DOI: 10.12290/xhyxzz.20210005
    [6]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅳ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 650-657. DOI: 10.12290/xhyxzz.20210004
    [7]Chinese Society of Surgery, Chinese Society of Anesthesiology. Clinical Practice Guidelines for ERAS in China(2021)(Ⅲ)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 641-649. DOI: 10.12290/xhyxzz.20210003
    [8]LI Xirong. Multi-modal Deep Learning and Its Applications in Ophthalmic Artificial Intelligence[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 602-607. DOI: 10.12290/xhyxzz.2021-0500
    [9]Fenglin Liu, Jing Qin. From Guidelines to Practice: Analysis of Guidelines for Prevention and Management of Perioperative Venous Thrombosis in General Surgery in China[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(2): 144-149. DOI: 10.3969/j.issn.1674-9081.2018.02.008
    [10]Manual of Orthopaedics(7th ed.) (2012)[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(2): 201-201.

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (314) PDF downloads (15) Cited by()
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close